Immunotherapy

915 articles

Research
June 17, 2022 • 3 Min

New Gene Inhibitor Drug for Patients with MTAP-Deleted Tumors

A new trial targets patients with advanced solid tumors, including pancreatic cancer, with an MTAP-deletion genetic mutation.

Press Releases
February 26, 2025 • 3 Min

Let’s Win Pancreatic Cancer Introduces New Features to Help Patients

In a new press release, Let’s Win introduces new features to help patients, including a Trial Finder and a Doctor Finder.

News
February 12, 2020 • 1 Min

Amazing Things—Dr. Allyson Ocean

Dr. Allyson Ocean is known for her warmth, and in a promotional video for NewYork-Presbyterian, former patient Corrine Cole explains why.

News
May 13, 2021 • 2 Min

LET’S WIN! PANCREATIC CANCER Turns 5!

Let’s Win has reached its 5th anniversary. Read about our development and what we have accomplished in 5 short years.

Survivor Stories
February 20, 2020 • 1 Min

Hope For All Stages

The doctors and researchers at the Penn Pancreatic Cancer Research Center examine different aspects of pancreatic cancer to find better treatments.

News
April 14, 2020 • 1 Min

Oncologists Are Struggling to Treat Cancer Patients Amid the Pandemic

Dr. Allyson Ocean explains the changes to her practice and risks she and her patients face as they battle cancer amid the COVID-19 pandemic.

News
September 19, 2019 • 1 Min

A Platinum Remembrance: The Power of Raising Your Voice

Gil Bashe and John Bianchi share a remembrance of Anne Glauber’s work and the power of advocacy on the eve of the Platinum PR Awards.

News
June 7, 2019 • 2 Min

Let’s Win! Pancreatic Cancer Updates Clinical Trials Section

Let’s Win announces updates to its clinical trials section on its website. These include a new clinical trial finder, animations,and educational pages.

News
March 27, 2019 • 1 Min

Let’s Win Pancreatic Cancer: Leading the Way Forward for Patients

The Biden Cancer Initiative has launched Pulse on Progress, an online magazine on Medium, and Let’s Win is featured in the first edition. The article focuses on how Let’s Win is changing the narrative around pancreatic cancer.

Research
July 18, 2018 • 3 Min

Adjuvant Chemotherapy with Modified FOLFIRINOX Regimen Improves Survival

A French clinical trial showed that adjuvant chemotherapy (given after surgery) with modified FOLFIRINOX improves survival of pancreatic cancer patients.

Research
February 25, 2021 • 2 Min

Adding Focused Radiation to Standard Pancreatic Cancer Treatment

Researchers are using IORT–intraoperative radiation therapy–to treat pancreatic cancer that cannot be surgically removed.

Page
September 14, 2022 • 7 Min

Finding a Clinical Trial

Let’s Win’s Trial Finder Clinical trials are important to consider for pancreatic cancer patients at all stages of the disease. Trials provide access to cutting-edge treatments not yet widely available, offering hope and potentially better outcomes. Studies are taking place at numerous locations across the United States, making participation more accessible than ever. Let’s Win […]

Page
November 13, 2024 • 5 Min

Pancreatic Neuroendocrine Tumors (PNETs)

Learn the Basics Steve Jobs and Aretha Franklin have more in common than being famous. Both also had the same rare form of pancreatic cancer, called pancreatic neuroendocrine tumors (PNETs). More recently, television host Maria Menounos received treatment for the same condition. To learn more about living with PNETs, read our stories of survivors who […]

In the News
November 29, 2023 • 1 Min

Let’s Win in a Spectrum News NY1 Report for Pancreatic Cancer Awareness Month

Cindy Gavin and Dr. Allyson Ocean appeared in a Spectrum News NY1 report on a pancreatic cancer patient, for Pancreatic Cancer Awareness Month.

Member
September 15, 2022 • 3 Min

Kerri Kaplan

Kerri Kaplan is the President of the Lustgarten Foundation, which is America’s largest private funder of pancreatic cancer research and is relentlessly focused on improving patient outcomes. Kerri oversees all aspects of the Lustgarten Foundation’s operational activities, including major fundraising initiatives, patient outreach, and the Foundation’s in-depth research portfolio. Early in her career at the […]